XML 47 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Business Acquisitions (Schedule by Acquisitions) (Details)
$ in Thousands
12 Months Ended
Sep. 20, 2021
USD ($)
Jul. 20, 2021
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
Major classes of assets and liabilities allocated to total fair value of consideration transferred          
Goodwill     $ 409,974   $ 409,974
Circulomics, Inc [Member]          
Business Combination, Consideration Transferred [Abstract]          
Total cash paid   $ 29,500      
Major classes of assets and liabilities allocated to total fair value of consideration transferred          
Cash and cash equivalents   987      
Property and equipment, net   214      
Intangible assets   11,360      
Goodwill   19,309      
Other assets   467      
Deferred income tax liability   (2,672)      
Liabilities assumed   (118)      
Total consideration transferred   $ 29,547      
Omniome, Inc [Member]          
Business Combination, Consideration Transferred [Abstract]          
Total cash paid $ 315,703        
Fair value of share consideration 249,435        
Fair value of contingent consideration 168,574        
Less: Share-based compensation expense excluded from consideration transferred (18,923)        
Total consideration transferred 714,789        
Major classes of assets and liabilities allocated to total fair value of consideration transferred          
Cash and cash equivalents 15,338        
Property and equipment, net 6,123        
Operating lease right-of-use assets, net 18,095        
In-process research and development ("IPR&D") 400,000        
Goodwill 390,665       $ 410,000
Other assets 3,203        
Deferred income tax liability (91,814)        
Liabilities assumed (26,821)        
Total consideration transferred $ 714,789        
Business Acquisition, Pro Forma Information [Abstract]          
Pro forma total revenue     130,513 $ 78,893  
Pro forma net (loss) income     $ (278,451) $ 17,510  
Pro forma net (loss) income per share - basic and diluted | $ / shares     (1.27) 0.09